Bone Biologics Co. (NASDAQ:BBLG – Get Free Report)’s share price rose 1.4% on Thursday . The stock traded as high as $0.70 and last traded at $0.68. Approximately 30,123 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 1,385,861 shares. The stock had previously closed at $0.67.
Bone Biologics Trading Up 1.4 %
The company has a 50 day simple moving average of $0.85 and a 200-day simple moving average of $1.12.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Featured Stories
- Five stocks we like better than Bone Biologics
- What is diluted earnings per share (Diluted EPS)?
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- How to Buy Gold Stock and Invest in Gold
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Consumer Discretionary Stocks Explained
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
